Results from a phase III trial Proton Therapy in Head and Neck Cancer

A groundbreaking multi-institution Phase III trial led by The University of Texas MD Anderson Cancer Center reveals that intensity modulated proton therapy (IMPT) provides significant benefits for patients with oropharyngeal cancer. Compared to traditional intensity modulated radiation therapy (IMRT), IMPT showed similar progression-free survival rates but significantly reduced malnutrition and feeding-tube dependence. With a median […]

nasopnaryngeal carcinoma radiotherapy dose
Twice daily radiotherapy for recurrent nasopharyngeal carcinoma

Nasopharyngeal carcinomas are most prevalent in South East Asia. Up to 10 to 20% of patients with nasopharyngeal carcinoma may experience a local relapse. Treatment options for recurrent nasopharyngealcarcinoma are dependent on a few factors. Time since first radiotherapy, extent of disease, and patient’s status etc. must be considered. Re-irradiation is one of these treatment […]

Skull base Chordoma
Skull base chordomas

Chordoma is a rare tumour which is thought to arise from remnants of the embryonic notochord (cartilage). Generally, it is slow-growing, although rarely, some chordomas can be more aggressive. It can grow anywhere along the spine column. Today we will discuss skull base chordomas specifically due to the complex treatment strategy required. Managing base of […]

radiotherapy face mask
Human Papilloma Virus related oral cancer

Surgery in oral cancers? Lower doses of radiotherapy for HPV cancers? Oropharyngeal carcinomas can be caused by environmental factors (smoking, alcohol etc.) or viral-driven. Human papillomavirus (HPV) infection, a common transmitted disease, has been associated with the development of many cancers, including oropharyngeal squamous cell carcinoma (OPSCC) of the head and neck. While traditional, environmentally […]

nasopnaryngeal carcinoma radiotherapy dose
Nasopharyngeal carcinoma and radiotherapy Radiotherapy techniques Radiotherapy is a very effective treatment for NPC. In early-stage NPC, the cure rate is over 90%. Even in more advanced stages, radiotherapy can shrink the tumor and improve symptoms. The cure rates from a large Chinese cohort study showed that even in patients with lower-staged cancers have a progression-free probability of […]